Therapeutic Improvement in People With Schizophrenia Undergoing tACS/CBTp (Transcranial Alternating Current Stimulation Applied Pre-cognitive Behavioral Therapy for Psychosis) Associated to Usual Medication Regimen

NANot yet recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 24, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2027

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
OTHER

Experimental: tASC/CBTp: gamma band electric stimulation for 20 minutes at the beginning of the CBTp session

For the transcranial stimulation we will use the tES device from NeuroMyst,. The gamma pulses are delivered to a study participant via stimulating electrodes positioned at participant's head according to the required technique. The tACS will be applied the first 20 minutes from the classic CBTp session for the experimental group.

OTHER

Sham Comparator

For the Sham group the investigators will use the same tES device from NeuroMyst. The Sham stimulation will be applied only for a few seconds in Sham group. The CBTp will follow the same protocol for both arms.

Trial Locations (1)

K7L7X3

Providence Care Hospital, Kingston

All Listed Sponsors
collaborator

Providence Care Hospital - Providence Care

UNKNOWN

collaborator

Queen's University

OTHER

lead

Felicia Iftene

OTHER

NCT06889025 - Therapeutic Improvement in People With Schizophrenia Undergoing tACS/CBTp (Transcranial Alternating Current Stimulation Applied Pre-cognitive Behavioral Therapy for Psychosis) Associated to Usual Medication Regimen | Biotech Hunter | Biotech Hunter